Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated October 12, 2023, titled "CEQUA showed sustained improvement in dry eye disease patients switched from Restasis".
Press Release Oct 12 2023
Filed with NSE ·
6ix hasn’t read this filing yet.
Sun Pharmaceutical Industries Limited on 6ix
Earlier from Sun Pharmaceutical Industries
- Press Release Oct 06 2023
- Press Release Sep 27 2023
- Press Release Sep 14 2023
- Press Release Aug 03 2023
- Sun Pharma Announces Health Canada Approval of (PR)ABSORICA LD® (isotretinoin capsules) for Treatment of Severe Nodular Acne
Later from Sun Pharmaceutical Industries
- Press Release Oct 16 2023
- Press Release Oct 30 2023
- Press Release Nov 01 2023
- Press Release Jan 17 2024
- Press Release Jan 31 2024
Follow Sun Pharmaceutical Industries into a list and get an email when it puts out news.
Follow Sun Pharmaceutical Industries